Fig. 18From: Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trialsExpanded disability status scale of multiple sclerosis after MSC therapyBack to article page